Quick Answer
AVENUE THERAPEUTICS, INC. reported Stockholders Equity of $1.83 million for fiscal year 2025.
AVENUE THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.83M | -34.5% |
| 2024 | $2.80M | +76.8% |
| 2023 | $1.58M | -59.5% |
| 2022 | $3.90M | +13.2% |
| 2021 | $3.45M | +46.3% |
| 2020 | $2.36M | -65.3% |
| 2019 | $6.80M | +1177.7% |
| 2018 | -$631.0K | -103.3% |
| 2017 | $19.38M | +335.0% |
| 2016 | -$8.25M | -60.6% |
| 2015 | -$5.13M | — |
| 2015 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.56M | +36.3% | -12.3% |
| June 30, 2025 | $4.06M | -14.8% | +15.6% |
| March 31, 2025 | $3.51M | +23.8% | +25.5% |
| December 31, 2024 | $2.80M | +76.8% | +7.2% |
| September 30, 2024 | $2.61M | +171.5% | -45.2% |
| June 30, 2024 | $4.76M | +189.3% | +68.0% |
| March 31, 2024 | $2.84M | +295.3% | +79.3% |
| December 31, 2023 | $1.58M | -59.5% | +143.3% |
- AVENUE THERAPEUTICS, INC. showed a decrease of -34.5% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from AVENUE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: